Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm
Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg
tablet of IVAX Pharmaceuticals, USA in healthy, adult, human, male subjects under fasting
condition